Mankind Pharma completed the acquisition of Bharat Serums and Vaccines from Advent International for $1.6bn.

Mankind Pharma, an Indian drugmaker, completed the acquisition of Bharat Serums and Vaccines, a biopharmaceutical company, from Advent International, a private equity investor, for $1.6bn. "We believe the women's health and fertility segment has massive opportunity along with strong growth visibility globally," Rajeev Juneja, Mankind Pharma Managing Director.